The company, led by Nobel Prize-winning scientists, is developing proprietary computational tools and scientific platforms to achieve accurate prediction of molecular and ensemble properties of biological systems. InterX's focus is on drug discovery, with the goal of creating novel therapeutic molecules through pharmaceutical ligand design, material science, and biochemistry. Additionally, InterX partners with pharma companies, start-ups, academia, and research organizations to jointly develop novel therapies, applying their expertise, know-how, and tools. For more information, contact InterX at [email protected].